Patients with COPD and type 2 diabetes using SGLT2i were much less likely to have ER visits and hospitalizations related to COPD exacerbations.

Alexandra Domrongchai is a food and travel writer based out of New York. With years of experience in the restaurant industry, food culture research, and as an avid traveler traveling she joins ...

Additionally, a subset of people living with COPD also have a high number of a type of white blood cell, called blood ...

The following is a summary of “Stereotactic radiosurgery alone for brain arteriovenous malformations: a single-institute experience,” published in the September 2024 issue of Neurology by Zhu et al.

Significant heterogeneity across studies was noted for intubation and hospital stay. In a subgroup of studies that included patients with severe COPD exacerbations (defined as pH<7.3 or in ...

These findings suggest that dupilumab could be an important new treatment option for patients who have COPD with type 2 inflammation, providing hope for those with severe lung impairment.

It is believed to connect the mind and body and improve overall well-being. Learn more about the different types of yoga. Starting something new can be intimidating, especially if you are unsure ...

Regeneron estimates about 300,000 people in the U.S. have the specific type of COPD that would make them eligible for treatment with Dupixent, which is administered via injection under the skin. The ...

for certain patients with chronic obstructive pulmonary disease (COPD), a respiratory disorder. With its latest approval, the inflammatory disease therapy, already approved in the U.S. for ...

“With Dupixent we really focus on type 2 inflammation within the COPD patient population. And then with itepekimab we focus on former smokers. That approach seems to be working better than ...

This approval makes dupilumab the first biologic treatment for COPD. It is a human monoclonal antibody that inhibits the signaling of IL-4 and IL-13 pathways, central drivers of the type 2 ...